FLT3 and acute myeloid leukemia: In addition, two recent studies reported the synergic effect of the combination of FLT3 (AC220/Quizartinib) and autophagy inhibitors (C43/spautin-1) [32] or (TAK165) [91] to efficiently kill AML cells.